This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krop, I. Articles by Polyak, K. Search for Related Content PubMed PubMed Citation Articles by Krop, I. Articles by Polyak, K.

A Putative Role for Psoriasin in Breast Tumor Progression

Departments of ¹ Medical Oncology and ² Biostatistical Science, Dana-Farber Cancer Institute; ³ Department of Medicine, Harvard Medical School; ⁴ Harvard School of Public Health; and ⁵ Department of Pathology, Beth Israel Deaconess Medical Center; ⁶ Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts; ⁷ Department of Tumor Virology, Heinrich-Pette-Institute, Hamburg, Germany; ⁸ Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden; and Departments of ⁹ Surgery and ¹⁰ Pathology, University of Michigan Cancer Center, Ann Arbor, Michigan

Requests for reprints: Kornelia Polyak, Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street D740C, Boston, MA 02115. Phone: 617-632-2106; Fax: 617-632-4005; E-mail: Kornelia_Polyak{at}dfci.harvard.edu.

Psoriasin (S100A7) was identifi`ed as a gene highly expressed in psoriatic keratinocytes and highly and more frequently expressed in ductal carcinoma in situ (DCIS) than in invasive breast carcinomas (IBC), suggesting a potential role in tumor progression. Psoriasin expression is associated with poor prognostic factors in both DCIS and IBC. Several putative functions have been proposed for psoriasin in various disease types, but none of these can fully explain its involvement in breast tumor progression. Here, we show that down-regulation of endogenous psoriasin expression via stable short hairpin RNAs in a human IBC cell line (MDA-MB-468) increases cell migration and invasion without influencing cell proliferation and survival in vitro but inhibits tumor growth in vivo. These seemingly paradoxical results are potentially explained by the dramatic up-regulation and down-regulation of matrix metalloproteinase-13 and vascular endothelial growth factor (VEGF), respectively, observed in cells with decreased psoriasin levels compared with controls. Correlating with this, high psoriasin expression in human IBC is associated with increased angiogenesis and worse clinical outcome, and psoriasin mRNA levels are coordinately regulated with VEGF and other genes related to hypoxia and mitochondrial reactive oxygen species (ROS). Based on these results, we propose that psoriasin may play a role in breast tumor progression by promoting angiogenesis and enhancing the selection for cells that overcome its anti-invasive function. This hypothesis may explain why psoriasin expression is highest in high-grade and/or estrogen receptor–negative tumors, as these are associated with increased hypoxia and ROS, a setting in which the angiogenic effects of psoriasin are most important. (Cancer Res 2005; 65(24): 11326-34)

This article has been cited by other articles:

				R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173. [Abstract] [Full Text] [PDF]

				H Zhang, Q Zhao, Y Chen, Y Wang, S Gao, Y Mao, M Li, A Peng, D He, and X Xiao Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas Thorax, April 1, 2008; 63(4): 352 - 359. [Abstract] [Full Text] [PDF]

				R. P.C. Wong, P. Ng, S. Dedhar, and G. Li The role of integrin-linked kinase in melanoma cell migration, invasion, and tumor growth Mol. Cancer Ther., June 1, 2007; 6(6): 1692 - 1700. [Abstract] [Full Text] [PDF]